Compassionate physician with substantial knowledge in diagnosing and treating patients in the various healthcare settings. Hardworking and empathetic individual with strong organizational and communication skills.
LIDERSHIP POSITIONS:
President of Scientific Student Society of the Khanty-Mansiysk Medical Academy, (2005-2008).
A Phase 3 Study of the Fafaty and Contraceptive Safaty of Relugolix Combination Therapy in Women with Uterine Fibroids od Endometriosis who at risk for Pregnancy. MVT-601-050. Sponsor: Myovant Sciences GmbH, Switzerland. Pr. Investigator: Dr Hidalgo, Ausberto. 12 Aug 2020 - opened.
A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ampligen® in Patients With Post-COVID Conditions. AMP-518. Sponsor: AIM ImmunoTech Inc. Pr Investigator Dr Hidalgo, A. June 30 - opened.
Mudrova, E. and Isakova, E. "Early Ventricle Repolarization as a Marker Pro-arrhythmic Activity in Patients with CHF." Tumen Medical Journal 23 (2008): 20-21.
Mudrova, E. “The influence of connective tissue dysplasia syndrome on development of restenosis after coronary angioplasty in CAD patients.” Khanty-Mansiysk Scientific Medical Journal 26 (2006): 10-11.
Mudrova, E. and Romanenko, S. "Dysplastic Syndrome Prevalence Among People of Far North." Khanty-Mansiysk Scientific Medical Journal 21 (2005): 13-14.